A $6 billion deal is at stake as OxyContin maker Purdue Pharma LP and its wealthy owners clash with the U.S. Justice Department over the company’s opioid lawsuit settlement. The parties will argue in a New York courtroom on Friday over a plan to funnel billions of dollars to opioid crisis relief efforts while also… Continue reading Purdue Pharma Squares Off with DOJ Over $6 Billion OxyContin Deal
Looking For Market Distribution? Download the Media Kit
